These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3289500)

  • 1. [Drug delivery systems].
    Mizushima Y
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1827-32. PubMed ID: 3289500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled application and scheduled removal of nanoparticle based chemotherapeutics (CARL) will reduce dose limiting adverse events in anticancer chemotherapy.
    Pütz G; Schmah O; Eckes J; Hug MJ; Winkler K
    Med Hypotheses; 2009 Apr; 72(4):393-7. PubMed ID: 19147297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Outpatient cancer chemotherapy employing implantable systems].
    Arai Y; Kido C; Ariyoshi Y
    Gan To Kagaku Ryoho; 1991 Dec; 18(15):2504-8. PubMed ID: 1746965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current problems and future perspectives in drug delivery systems for cancer therapy].
    Mizushima Y; Shoji Y; Saotome T; Yanagawa A; Nakagawa T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1077-82. PubMed ID: 3291768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience in the use of Soviet-made drug delivery systems in the chemotherapy of malignant tumors].
    Perevodchikova NI; Gorbunova VA; Shatikhin VA; Roshchin EM; Dolgushin BI
    Sov Med; 1988; (9):28-31. PubMed ID: 3212554
    [No Abstract]   [Full Text] [Related]  

  • 6. [Application of novel drug delivery system, fusogenic liposome, for cancer therapy].
    Kunisawa J; Mayumi T
    Gan To Kagaku Ryoho; 2001 May; 28(5):577-83. PubMed ID: 11383204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle and targeted systems for cancer therapy.
    Brannon-Peppas L; Blanchette JO
    Adv Drug Deliv Rev; 2004 Sep; 56(11):1649-59. PubMed ID: 15350294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug stability and compatibility in oncology care.
    Williams DA
    J Infus Chemother; 1996; 6(4):195-202. PubMed ID: 9229315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of pro-drug therapy in the treatment of cancer.
    Ferguson MJ; Ahmed FY; Cassidy J
    Drug Resist Updat; 2001 Aug; 4(4):225-32. PubMed ID: 11991677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Improvements in placement of implantable drug delivery catheter for prevention and treatment of hepatic metastases from colorectal cancer].
    Takeda Y; Mieno K; Okushima S; Amino K; Ohtaki K; Miura S; Shikata J
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2374-8. PubMed ID: 3415250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rationale for non-zero-order drug delivery using automatic, computer-based drug delivery systems (chronotherapy).
    Hrushesky WJ
    J Biol Response Mod; 1987 Dec; 6(6):587-98. PubMed ID: 3450783
    [No Abstract]   [Full Text] [Related]  

  • 12. Physical mechanisms and methods employed in drug delivery to tumors.
    Besić E
    Acta Pharm; 2007 Sep; 57(3):249-68. PubMed ID: 17878107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation-guided drug delivery systems.
    Stacy DR; Lu B; Hallahan DE
    Expert Rev Anticancer Ther; 2004 Apr; 4(2):283-8. PubMed ID: 15056058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experience of a subcutaneously implantable drug delivery catheter (PORT-A-CATH)].
    Kimura K; Koide A; Suga S; Shimoyama T; Okamoto E; Utsunomiya J; Okawa T; Taguchi T; Wakui A
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1150-5. PubMed ID: 3566308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new probe for targeting drug delivery system.
    Yu Z; Wang B; Sui J; Feng Y; Zheng C
    Med Hypotheses; 2009 Jan; 72(1):43-4. PubMed ID: 18829175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of new drug delivery system for primary lung cancer: intermittent intra-arterial injection therapy with implantable port system (reservoir)--II. Evaluation of technical methods for cannulation of feeding arteries of lung cancer with implantation of implantable port system].
    Shinozaki Y; Hara F; Mushiake H; Morita I; Nakajima T; Nagao T; Nishioka S; Kojou T
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):209-14. PubMed ID: 7857094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle therapeutics: an emerging treatment modality for cancer.
    Davis ME; Chen ZG; Shin DM
    Nat Rev Drug Discov; 2008 Sep; 7(9):771-82. PubMed ID: 18758474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles for delivery of chemotherapeutic agents to tumors.
    Vijayaraghavalu S; Raghavan D; Labhasetwar V
    Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable pumps.
    Sefton MV
    Crit Rev Biomed Eng; 1987; 14(3):201-40. PubMed ID: 3297487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Targetting therapy for cancer and drug delivery system].
    Taguchi T
    Gan To Kagaku Ryoho; 1994 May; 21(6):736-7. PubMed ID: 8185327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.